Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
Open Access
- 9 January 2007
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (1) , 104-109
- https://doi.org/10.1038/sj.bjc.6603530
Abstract
Tumour hypoxia is a microenvironmental factor related to poor response to radiation, chemotherapy, genetic instability, selection for resistance to apoptosis, and increased risk of invasion and metastasis. Hypoxia-regulated carbonic anhydrase IX (CA IX) has been studied in various tumour sites and its expression has been correlated with the clinical outcome. The purpose of this study was to investigate the correlation of CA IX expression with outcome in patients with invasive breast cancer. We conducted a retrospective study examining the effects of carbonic anhydrase IX (CA IX) on survival in patients with breast cancer. To facilitate the screening of multiple tissue blocks from each patient, tissue microarrays were prepared containing between two and five representative samples of tumour per patient. Immunohistochemistry was used to examine expression of CA IX in patients with breast cancer. The study includes a cohort of 144 unselected patients with early invasive breast cancer who underwent surgery, and had CA IX expression and follow-up data available for analysis. At the time of analysis, there were 28 deaths and median follow-up of 48 months with 96% of patients having at least 2 years of follow-up. CA IX was negative for 107 patients (17 deaths) and positive for 37 patients (11 deaths). Kaplan–Meier survival curves show that survival was superior in the CA IX-negative group with a 2-year survival of 97% for negatives and 83% for positives (log-rank test P=0.01). Allowing for potential prognostic variables in a Cox regression analysis, CA IX remained a significant independent predictor of survival (P=0.035). This study showed in both univariate and multivariate analysis that survival is significantly inferior in patients with tumour expressing CA IX. Prospective studies are underway to investigate this correlation in clinical trial setting.Keywords
This publication has 30 references indexed in Scilit:
- Simultaneous evaluation of maspin and CXCR4 in patients with breast cancerJournal of Clinical Pathology, 2006
- Carbonic Anhydrase IX Expression and Tumor Oxygenation Status Do Not Correlate at the Microregional Level in Locally Advanced Cancers of the Uterine CervixClinical Cancer Research, 2005
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004
- Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiotherapy and Oncology, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastasesInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Intratumoral PO2 Histography as Predictive Assay in Advanced Cancer of the Uterine CervixPublished by Springer Nature ,1994
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- A novel quasi-viral agent, MaTu, is a two-component systemVirology, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958